InflaRx (IFRX) Shares Issued (2017 - 2025)

InflaRx's (IFRX) quarterly Shares Issued came in at $7.9 million in Q4 2025, down 53.68% quarter-over-quarter from $17.0 million in Q1 2025.

InflaRx (IFRX) Shares Issued (2017 - 2025) Analysis & Trends

InflaRx has disclosed Shares Issued across 6 years of filings, most recently posting $7.9 million for Q4 2025.

Shares Issued for Q4 2025 came in at $7.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $24.8 million (changed N/A YoY), and the FY2025 annual result was $26.7 million, up 2171.39% from the prior year.
Shares Issued came in at $7.9 million for Q4 2025 at InflaRx, down from $17.0 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $73.4 million in Q4 2021 to a low of $123044.1 in Q2 2023.
The 3-year median for Shares Issued is $7.9 million (2025), against an average of $22.9 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	5.40 Mn
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	27.00 Mn
9	Abivax	94.26 Bn	94.26 Bn	-	26,927.15
10	InflaRx	764.68 Mn	764.68 Mn	10,877.40	-

Download Data